Frequency and phenotypic characteristics of RPE65 mutations in the Chinese population

BACKGROUND: The retinoid isomerohydrolase RPE65 has received considerable attention worldwide since a successful clinical gene therapy was approved in 2017 as the first treatment for vision loss associated with RPE65-mediated inherited retinal disease. Identifying patients with RPE65 mutations is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Feng-Juan, Wang, Dan-Dan, Li, Jian-Kang, Hu, Fang-Yuan, Xu, Ping, Chen, Fang, Qi, Yu-He, Liu, Wei, Li, Wei, Zhang, Sheng-Hai, Chang, Qing, Xu, Ge-Zhi, Wu, Ji-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097799/
https://www.ncbi.nlm.nih.gov/pubmed/33952291
http://dx.doi.org/10.1186/s13023-021-01807-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097799/
https://www.ncbi.nlm.nih.gov/pubmed/33952291
http://dx.doi.org/10.1186/s13023-021-01807-3

Ejemplares similares